- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Bal Pharma Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting
11-02-2026 | 06:51 pm
11-02-2026 | 06:51 pm
Bal Pharma's Board approved Q3 FY26 consolidated results. Revenue surged to ₹87.69 Cr, marking a 20% YoY jump. Net Profit soared to ₹1.79 Cr, an impressive 245% increase compared to last year.
No comments yet. Be the first to comment!